In vivo xenograft results demonstrated that IL1R2 overexpression facilitated xenograft tumor growth (Figure S3I, Supporting Information) and increased BTICs in immunodeficient female mice (Figure S3J, Supporting Information). This evidence concerns the gene IL1R2 and neoplasm.